ART-TG accelerator of technological innovation in gene therapy

Enabling innovation in cell and gene therapy

56th Annual Meeting of the SFI Paris 2025

Find the ART-TG at the 56th Annual Meeting of the French Society for Immunology (SFI) from the 12th to the 14th Novembre 2025 in Paris Find out more about the program here PARALLEL SESSION Friday November 14th, 2025 SP19 - Gene and Cell Therapy 10h45-12h15 Anne GALY (Accelerator of Technological Research in Genomic Therapy, INSERM, Corbeil-Essonnes, France) Recent advances and remaining challenges in lentiviral transduction and gene editing of lymphocytes and hematopoietic s

Shaping the future of gene therapy

ART-TG will present at the annual meeting of ANRS on emerging diseases, Nov 28, 2025 at the Pasteur Institute in Paris. INFOS HERE

In the news

Expertise

dna-g624eb8017_1920 gerd altmann pixabay.jpg

Translational research in cell and gene therapy

Lentiviral vector production

About us

ART-TG is an innovation and development laboratory for cell and gene therapy, established by Inserm. Its mission is to accelerate the transfer of promising research discoveries towards clinical stages, which ultimately will ensure that the best gene therapies will be available for patients.

Anne Galy, founder of ART-TG (view her bio)

SEE MORE INFORMATION

Our projects are funded by

ART-TG is accessible by public transportation: about 400m from RER-D Bras de Fer-Genepole station